Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs
Nature Communications2014Vol. 5(1), pp. 4330–4330
Citations Over TimeTop 10% of 2014 papers
Guang Hui Liu, Keiichiro Suzuki, Mo Li, Jing Qu, Núria Montserrat, Carolina Tarantino, Ying Gu, Fei Yi, Xiuling Xu, Weiqi Zhang, Sergio Ruiz, Nongluk Plongthongkum, Kun Zhang, Shigeo Masuda, Emmanuel Nivet, Yuji Tsunekawa, Rupa Devi Soligalla, April Goebl, Emi Aizawa, Na Young Kim, Jessica Kim, Ilir Dubova, Ying Li, Ruotong Ren, Christopher Benner, Antonio del Sol, Juan A. Bueren, Juan Pablo Trujillo‐Quintero, Jordi Surrallés, Enrico Cappelli, Carlo Dufour, Concepción Rodrı́guez Esteban, Juan Carlos Izpisúa Belmonte
Related Papers
- → Mice with a targeted disruption of the Fanconi anemia homolog Fanca(2000)190 cited
- → Novel FANCA mutation in the first fully-diagnosed patient with Fanconi anemia in Polish population – case report(2020)3 cited
- → Fanca-/- hematopoietic stem cells demonstrate a mobilization defect which can be overcome by administration of the Rac inhibitor NSC23766(2009)14 cited
- → Enhanced frequency of sister chromatid exchanges induced by diepoxybutane is specific characteristic of Fanconi anemia cellular phenotype(2013)2 cited
- → Esophageal cancer as initial presentation of Fanconi anemia in patients with a hypomorphic FANCA variant(2020)21 cited